# Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice

> **NCT01273441** · PHASE4 · COMPLETED · sponsor: **Fundación de Investigación Biomédica - Hospital Universitario de La Princesa** · enrollment: 338 (actual)

## Conditions studied

- Helicobacter Pylori

## Interventions

- **DRUG:** PPI, amoxicillin, metronidazole and clarithromycin
- **DRUG:** PPI, amoxicillin, metronidazole and clarithromycin

## Key facts

- **NCT ID:** NCT01273441
- **Lead sponsor:** Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2012-06
- **Final completion:** 2012-07
- **Target enrollment:** 338 (ACTUAL)
- **Last updated:** 2023-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01273441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01273441, "Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01273441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*